- Home
- NIU vs INZY Comparison
NIU vs INZY Comparison
Compare NIU & INZY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIU
- INZY
- Stock Information
- Founded
- NIU 2014
- INZY 2015
- Country
- NIU China
- INZY United States
- Employees
- NIU N/A
- INZY N/A
- Industry
- NIU Auto Manufacturing
- INZY Biotechnology: Pharmaceutical Preparations
- Sector
- NIU Consumer Discretionary
- INZY Health Care
- Exchange
- NIU Nasdaq
- INZY Nasdaq
- Market Cap
- NIU 216.7M
- INZY 256.3M
- IPO Year
- NIU 2018
- INZY 2020
- Fundamental
- Price
- NIU $3.36
- INZY $4.00
- Analyst Decision
- NIU
- INZY Buy
- Analyst Count
- NIU 0
- INZY 9
- Target Price
- NIU N/A
- INZY $15.22
- AVG Volume (30 Days)
- NIU 1.1M
- INZY 989.2K
- Earning Date
- NIU 08-11-2025
- INZY 08-05-2025
- Dividend Yield
- NIU N/A
- INZY N/A
- EPS Growth
- NIU N/A
- INZY N/A
- EPS
- NIU N/A
- INZY N/A
- Revenue
- NIU $477,578,753.00
- INZY N/A
- Revenue This Year
- NIU $41.32
- INZY N/A
- Revenue Next Year
- NIU $24.38
- INZY N/A
- P/E Ratio
- NIU N/A
- INZY N/A
- Revenue Growth
- NIU 26.51
- INZY N/A
- 52 Week Low
- NIU $1.66
- INZY $0.72
- 52 Week High
- NIU $4.90
- INZY $6.24
- Technical
- Relative Strength Index (RSI)
- NIU 45.79
- INZY 82.66
- Support Level
- NIU $3.31
- INZY $3.94
- Resistance Level
- NIU $3.44
- INZY $3.97
- Average True Range (ATR)
- NIU 0.22
- INZY 0.01
- MACD
- NIU -0.02
- INZY -0.08
- Stochastic Oscillator
- NIU 29.63
- INZY 100.00
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.
About INZY Inozyme Pharma Inc.
Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.